Literature DB >> 26718033

Isolation and comparison of mesenchymal stem cell‑like cells derived from human gastric cancer tissues and corresponding ovarian metastases.

Kunyan Zhou1, Man Xia2, Bo Tang1, Darong Yang1, Nianli Liu3, Dihong Tang2, Hailong Xie4, Xiaohong Wang1, Haizhen Zhu1, Chen Liu5, Chaohui Zuo1.   

Abstract

Mesenchymal stem cell (MSC)-like cells have been isolated from various types of tumor. It has previously been reported that MSCs are involved in tumorigenesis and its prognosis. The aim of the present study was to isolate and compare MSC-like cells from human gastric cancer (GC) and its metastatic deposits in ovarian tissue. MSC-like cells were isolated from human gastric cancer (hGC-MSCs) and the corresponding ovarian metastatic tissues (hGCOM-MSCs) from 40 patients. The characteristics of hGC-MSCs and hGCOM-MSCs, including their morphology, surface antigens, specific gene expression and differentiation potential, were similar to those of MSCs derived from human bone marrow (hBM-MSCs) but different from GC cells. In conclusion, the present study demonstrated that MSC-like cells could be isolated from GC tissue and its ovarian metastatic tissues. The existence of MSC-like cells in GC tissues and its ovarian metastatic tissues suggests that they may be a potential target for cancer therapy, and provides an experimental foundation for investigating their role in the initiation and progression of ovarian metastasis of GC.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26718033     DOI: 10.3892/mmr.2015.4735

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

1.  Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.

Authors:  Maria E Gonzalez; Emily E Martin; Talha Anwar; Caroline Arellano-Garcia; Natasha Medhora; Arjun Lama; Yu-Chih Chen; Kevin S Tanager; Euisik Yoon; Kelley M Kidwell; Chunxi Ge; Renny T Franceschi; Celina G Kleer
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

Review 2.  Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review.

Authors:  Zahra Fazeli; Atieh Abedindo; Mir Davood Omrani; Sayyed Mohammad Hossein Ghaderian
Journal:  Stem Cell Rev Rep       Date:  2018-02       Impact factor: 5.739

3.  Tumor-derived mesenchymal-stem-cell-secreted IL-6 enhances resistance to cisplatin via the STAT3 pathway in breast cancer.

Authors:  Huitao Xu; Ying Zhou; Wei Li; Bin Zhang; Huanhuan Zhang; Shaolin Zhao; Ping Zheng; Huiyi Wu; Jin Yang
Journal:  Oncol Lett       Date:  2018-04-11       Impact factor: 2.967

4.  Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer.

Authors:  Song Shang; Jinfeng Wang; Shilin Chen; Renyun Tian; Hui Zeng; Liang Wang; Man Xia; Haizhen Zhu; Chaohui Zuo
Journal:  Cancer Med       Date:  2019-10-23       Impact factor: 4.452

5.  miRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer.

Authors:  Min Ma; Shilin Chen; Zhuo Liu; Hailong Xie; Hongyu Deng; Song Shang; Xiaohong Wang; Man Xia; Chaohui Zuo
Journal:  Onco Targets Ther       Date:  2017-08-22       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.